Albert Seymour, Chief Scientific Officer at Homology Medicines, Inc. (FIXX), sold 9,300 shares at $17.38 ($162K) on 2019-10-01, disclosed to the SEC on 2019-10-02.
Open-market sale of $162k FIXX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.38 | 9,200 | $160K | 98.9% |
| 2 | $18.23 | 100 | $2K | 1.1% |
| Total | $17.39 avg | 9,300 | $162K | 100% |
| Filing → |
| FIXX | SELL | 2022-01-12 | $6K | — | Filing → |
| FIXX | SELL | 2021-01-08 | $362K | — | Filing → |
| FIXX | SELL | 2021-01-07 | $114K | — | Filing → |